Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone
- PMID: 3137242
- DOI: 10.1210/jcem-67-3-474
Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone
Abstract
Premature thelarche is a benign condition that affects young girls. In contrast, central precocious puberty is considered a more serious disorder that causes progressive secondary sexual development, accelerated growth and skeletal maturation, early epiphyseal fusion, and short adult stature. Differentiation between these 2 conditions is important, but may be difficult on clinical grounds, since patients with both disorders may present initially as isolated breast development. To examine the potential usefulness of gonadotropin measurements in distinguishing early central precocious puberty from premature thelarche, we measured basal and LHRH-stimulated plasma gonadotropin levels in 58 girls with idiopathic premature breast development. The girls were divided into six clinically distinct groups, based on the severity of clinical presentation, ranging from isolated breast development (group A) to complete secondary sexual development and accelerated growth and skeletal maturation (group F). The mean basal plasma LH levels and the peak LH response to LHRH stimulation were significantly less in girls with isolated thelarche (group A) than in girls with complete sexual development (group F). The mean basal plasma FSH levels did not differ between these groups, but the peak FSH response to LHRH was greater in girls with isolated thelarche than in girls with complete sexual development. Thus, girls with isolated premature thelarche had a FSH-predominant response to LHRH [mean ratio of peak LH to peak FSH, 0.29 +/- 0.10 (+/- SD)], while girls with complete sexual development had a LH-predominant response (peak LH/FSH, 4.16 +/- 1.80). All girls with isolated thelarche had peak LH/FSH ratios less than 1, and all girls with complete sexual development had a ratio greater than 1. Girls with early or intermediate manifestations of central precocious puberty, who had features of puberty in addition to breast development but lacked all of the features of group F, comprised groups B-E. These girls also had intermediate peak LH/FSH ratios, ranging from 0.29 +/- 0.10 (group B) to 3.35 +/- 2.66 (group E). We conclude that girls with early central precocious puberty frequently have LH and FSH responses to LHRH that are indistinguishable from the FSH-predominant responses of girls with isolated thelarche. These data are consistent with the hypothesis that premature thelarche and central precocious puberty may represent different positions along a continuum of hypothalamic LHRH neuron activation.
Similar articles
-
[The differentiation between premature thelarche and pubertas praecox on the basis of clinical, hormonal and radiological findings].Dtsch Med Wochenschr. 1994 Sep 30;119(39):1301-6. doi: 10.1055/s-2008-1058836. Dtsch Med Wochenschr. 1994. PMID: 7924927 German.
-
Gonadotropin-releasing hormone testing in premature thelarche.J Med Assoc Thai. 1999 Nov;82 Suppl 1:S33-8. J Med Assoc Thai. 1999. PMID: 10730515
-
The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.J Clin Endocrinol Metab. 2014 Feb;99(2):433-9. doi: 10.1210/jc.2013-3292. Epub 2013 Dec 2. J Clin Endocrinol Metab. 2014. PMID: 24297793
-
[Central precocious puberty].Ann Pediatr (Paris). 1989 Dec;36(10):653-8. Ann Pediatr (Paris). 1989. PMID: 2696410 Review. French.
-
Premature Thelarche: An Updated Review.Curr Pediatr Rev. 2024;20(4):500-509. doi: 10.2174/1573396320666230726110658. Curr Pediatr Rev. 2024. PMID: 37496240 Review.
Cited by
-
Central precocious puberty: current treatment options.Paediatr Drugs. 2004;6(4):211-31. doi: 10.2165/00148581-200406040-00002. Paediatr Drugs. 2004. PMID: 15339200 Review.
-
Clinical and Laboratory Parameters of Gonadotropin-Releasing Hormone Analog Treatment Effectiveness in Children with Precocious Puberty.Clinics (Sao Paulo). 2019 Nov 7;74:e1205. doi: 10.6061/clinics/2019/e1205. eCollection 2019. Clinics (Sao Paulo). 2019. PMID: 31721934 Free PMC article.
-
Diagnostic Accuracy of Female Pelvic Ultrasonography in Differentiating Precocious Puberty From Premature Thelarche: A Systematic Review and Meta-analysis.Front Endocrinol (Lausanne). 2021 Sep 1;12:735875. doi: 10.3389/fendo.2021.735875. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34539579 Free PMC article.
-
Pros and cons of GnRHa treatment for early puberty in girls.Nat Rev Endocrinol. 2014 Jun;10(6):352-63. doi: 10.1038/nrendo.2014.40. Epub 2014 Apr 8. Nat Rev Endocrinol. 2014. PMID: 24709660 Review.
-
Observational study pelvic ultrasound a useful tool in the diagnosis and differentiation of precocious puberty in Chinese girls.Medicine (Baltimore). 2018 Mar;97(10):e0092. doi: 10.1097/MD.0000000000010092. Medicine (Baltimore). 2018. PMID: 29517679 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources